Change search
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf
Tissue specific expression of the transcription factor SATB2 in colorectal carcinoma
KTH, School of Biotechnology (BIO).ORCID iD: 0000-0001-7034-0850
KTH, School of Biotechnology (BIO).
KTH, School of Biotechnology (BIO).ORCID iD: 0000-0001-8993-048X
2008 (English)Article in journal (Other academic) Submitted
Place, publisher, year, edition, pages
2008.
Keyword [en]
SATB2; colorectal cancer; antibody-based proteomics; diagnostics; prognostic factors
National Category
Industrial Biotechnology
Identifiers
URN: urn:nbn:se:kth:diva-4884OAI: oai:DiVA.org:kth-4884DiVA: diva2:1756
Note
QS 20120314Available from: 2008-09-16 Created: 2008-09-16 Last updated: 2012-03-14Bibliographically approved
In thesis
1. Bioimaging for analysis of protein expression in cells and tissues using affinity reagents
Open this publication in new window or tab >>Bioimaging for analysis of protein expression in cells and tissues using affinity reagents
2008 (English)Doctoral thesis, comprehensive summary (Other scientific)
Abstract [en]

The detection and analysis of biomolecules, such as proteins, are of great interest since these molecules are fundamental for life and our health. Due to the complexity of biological processes, there is a great advantage of studying proteins in their natural context, for example by using bioimaging. The objective of this doctoral thesis has been to develop, implement and evaluate techniques for the use of proteinspecific affinity reagents in diverse bioimaging platforms for analysis of protein expression in situ in cells and tissues.

To be able to visualize a desired protein in situ using affinity reagents, reporter labels are needed. A novel technique for labeling of antibodies on solid phase was developed. This method offers simultaneous purification, concentration and labeling of an antibody sample, giving highly predictable and reproducible results, in a miniaturized format.

Another study demonstrates the use of an alternative affinity reagent, the Affibody molecule, in bioimaging as well as other immunoassays. As a relevant proof-of-principle, an Affibody molecule binding the HER2 receptor was site-specificly labeled and employed for analysis of HER2 protein expression in cells and tissue using immunofluorescence (IF), immunohistochemistry (IHC), immunoprecipitation and flow cytometry.

Furthermore, it is shown how antibody-based bioimaging approaches can be applied for systematic analysis of protein expression in terms of subcellular localization and expression levels in cell lines. The systematic subcellular localization of nearly 500 proteins was performed using IF and confocal microscopy. Global analysis of expression levels of nearly 2000 proteins in a panel of cell lines using IHC and automated image analysis, revealed that most proteins are expressed in a cell size dependent manner. Two normalization approaches were evaluated and found to allow for protein profiling across the panel of morphologically diverse cells, revealing patterns of protein over- and underexpression, and proteins with stable as well as with lineage specific expression were identified.

Finally, the value of antibody-based, bioimaging proteomics as a platform for biomarker discovery is demonstrated. The identification and in depth study of a candidate biomarker for colorectal cancer, SATB2, is described using both IHC and IF bioimaging. Results from extended analyses of tumor biopsies showed that detection of SATB2 protein using IHC provides a clinically relevant diagnostic tool with high specificity and sensitivity to aid in diagnosis of colorectal cancer. Furthermore, the study demonstrated a potential prognostic role of SATB2, as decreased expression was associated with a significantly shorter overall survival in patients with advanced colorectal cancer.

Place, publisher, year, edition, pages
Stockholm: KTH, 2008. vii, 86 p.
Series
Trita-BIO-Report, ISSN 1654-2312 ; 2008:14
Keyword
Affibody, antibody, biomarker, cell line, cell microarray, colorectal cancer, confocal microscopy, HER2, immunohistochemistry, immunofluorescence, light microscopy, protein expression, protein localization, SATB2, tissue microarray
National Category
Industrial Biotechnology Biochemistry and Molecular Biology
Identifiers
urn:nbn:se:kth:diva-4862 (URN)978-91-7415-096-4 (ISBN)
Public defence
2008-09-26, FD5, AlbaNova Universitetscentrum, Kungl Tekniska Högskolan, Roslagstullsbacken 21, Stockholm, 10:00 (English)
Opponent
Supervisors
Note
QC 20100824Available from: 2008-09-05 Created: 2008-09-05 Last updated: 2010-08-24Bibliographically approved

Open Access in DiVA

No full text

Authority records BETA

Lundberg, EmmaUhlén, Mathias

Search in DiVA

By author/editor
Lundberg, EmmaGry, MarcusUhlén, Mathias
By organisation
School of Biotechnology (BIO)
Industrial Biotechnology

Search outside of DiVA

GoogleGoogle Scholar

urn-nbn

Altmetric score

urn-nbn
Total: 62 hits
CiteExportLink to record
Permanent link

Direct link
Cite
Citation style
  • apa
  • harvard1
  • ieee
  • modern-language-association-8th-edition
  • vancouver
  • Other style
More styles
Language
  • de-DE
  • en-GB
  • en-US
  • fi-FI
  • nn-NO
  • nn-NB
  • sv-SE
  • Other locale
More languages
Output format
  • html
  • text
  • asciidoc
  • rtf